Cognex: Turning To AI And New Markets To Reignite Growth (NASDAQ:CGNX)
Seeking Alpha· 2026-02-05 23:31
The last couple of years have proven that automation isn’t immune to larger macroeconomic cycles, as many companies have pulled back on their spending in the face of weaker demand and greater uncertainty. That has made life difficult for Cognex (Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving ...
Cognex: Turning To AI And New Markets To Reignite Growth
Seeking Alpha· 2026-02-05 23:31
The last couple of years have proven that automation isn’t immune to larger macroeconomic cycles, as many companies have pulled back on their spending in the face of weaker demand and greater uncertainty. That has made life difficult for Cognex (Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving ...
Microchip Technology (MCHP) Q3 Earnings and Revenues Top Estimates
ZACKS· 2026-02-05 23:30
Microchip Technology (MCHP) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.2 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +3.38%. A quarter ago, it was expected that this chipmaker would post earnings of $0.33 per share when it actually produced earnings of $0.35, delivering a surprise of +6.06%.Over the last four quarters, the co ...
Monolithic (MPWR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
ZACKS· 2026-02-05 23:30
For the quarter ended December 2025, Monolithic Power (MPWR) reported revenue of $751.16 million, up 20.8% over the same period last year. EPS came in at $4.79, compared to $4.09 in the year-ago quarter.The reported revenue represents a surprise of +1.41% over the Zacks Consensus Estimate of $740.72 million. With the consensus EPS estimate being $4.73, the EPS surprise was +1.3%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to deter ...
ViaSat (VSAT) Q3 Earnings Top Estimates
ZACKS· 2026-02-05 23:30
ViaSat (VSAT) came out with quarterly earnings of $0.79 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to a loss of $1.23 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +1,404.76%. A quarter ago, it was expected that this provider of satellite and wireless networking technology would post a loss of $0.11 per share when it actually produced earnings of $0.09, delivering a surprise of +181.82% ...
Regency Centers (REG) Q4 FFO Match Estimates
ZACKS· 2026-02-05 23:30
Regency Centers (REG) came out with quarterly funds from operations (FFO) of $1.17 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $1.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an FFO surprise of +0.09%. A quarter ago, it was expected that this shopping center real estate investment trust would post FFO of $1.15 per share when it actually produced FFO of $1.15, delivering no surprise.Over the last four quarters, ...
Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288
Globenewswire· 2026-02-05 23:30
ROCKVILLE, Md. and SUZHOU, China, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that its novel next-generation Bruton's tyrosine kinase (BTK)-targeted protein degrader, APG-3288, has received investigational new drug (IND) application clearance fr ...
IAUI: Own Gold With A Built-In Cushion And Earn Too
Seeking Alpha· 2026-02-05 23:27
The NEOS Gold High Income ETF ( IAUI ) appears to be very well placed as an income fund generally — it obviously caps upsides in strong gold rallies, but the limited data since inception shows it is doingI am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investment opportunities. As a former Vice President at Barclays, I led teams in model va ...
Equity Residential (EQR) Q4 FFO and Revenues Miss Estimates
ZACKS· 2026-02-05 23:26
Equity Residential (EQR) came out with quarterly funds from operations (FFO) of $1.03 per share, missing the Zacks Consensus Estimate of $1.04 per share. This compares to FFO of $1 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an FFO surprise of -0.74%. A quarter ago, it was expected that this real estate investment trust would post FFO of $1.02 per share when it actually produced FFO of $1.02, delivering no surprise.Over the last four quarters, th ...
Gen Digital (GEN) Beats Q3 Earnings and Revenue Estimates
ZACKS· 2026-02-05 23:26
Gen Digital (GEN) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.56 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +1.19%. A quarter ago, it was expected that this security software maker would post earnings of $0.61 per share when it actually produced earnings of $0.62, delivering a surprise of +1.64%.Over the last four quarters, t ...